Limited CD4+ T-cell renewal in early HIV-1 infection: Effect of highly active antiretroviral therapy

Nature Medicine

Volumn 4, Issue 7, 1998, Pages 794-801

  Fleury, Sylvain ^a   De Boer, Rob J ^b   Rizzardi, G Paolo ^a   Wolthers, Katja C ^c   Otto, Sigrid A ^c   Welbon, Craig C ^a   Graziosi, Cecilia ^a,e   Knabenhans, Christian ^a   Soudeyns, Hugo ^a   Bart, Pierre Alexandre ^a   Gallant, Serge ^a   Corpataux, Jean Marc ^a   Gillet, Michel ^a   Meylan, Pascal ^e   Schnyder, Pierre ^a   Meuwly, Jean Yves ^a   Spreen, William ^d   Glauser, Michel P ^a   Miedema, Frank ^c   Pantaleo, Giuseppe ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b UTRECHT UNIVERSITY   (Netherlands)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

^d GLAXOSMITHKLINE   (United States)

^e UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; AMPRENAVIR; CD4 ANTIGEN; CD8 ANTIGEN;

ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; VIRUS INHIBITION; VIRUS REPLICATION;

ADULT; AGED; ANTI-HIV AGENTS; CARBAMATES; CD4-CD8 RATIO; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL DIVISION; DIDEOXYNUCLEOSIDES; DRUG THERAPY, COMBINATION; FEMALE; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HUMANS; KI-67 ANTIGEN; LYMPH NODES; MALE; MIDDLE AGED; REVERSE TRANSCRIPTASE INHIBITORS; SULFONAMIDES;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0031873665     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm0798-794     Document Type: Article

References (26)

1. Wei, X. et al. Viral dynamics in human immunodeficency virus type 1 infection. Nature 373, 117-122 (1995).
2. Ho, D.D. et al. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 373, 123-126 (1995).
3. Mohri, H., Bonhoeffer, S., Monard, S., Perelson, A.S. & Ho, D.D. Rapid turnover of T lymphocytes in SIV-infected Rhesus Macaques. Science 279, 1223-1227 (1998).
4. Wolthers, K.C. et al. T cell telomere length in HIV-1 infection: No evidence for increased CD4+T cell turnover. Science 274, 1543-1547 (1996).
5. Pakker, N.C. et al. Biphasic kinetics of peripheral blood T cells after triple combination therapy in HIV-1 infection: a composite of redistribution and proliferation. Nature Med. 4, 208-214 (1998).
6. Gerdes, J. et al. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J. Immunol. 133, 1710-1715 (1984).
7. Bruno, S. & Darzynkiewic, Z. Cell cycle dependent expression and stability of the nuclear protein detected by Ki-67 antibody in HL-60 cells. Cell Prolif. 25, 31-41 (1992).
8. Schwarting, R., Gerdes, J., Niehus, J., Jaeschke, L. & Stein, H. Determination of the growth fraction in cell suspensions by flow cytometry using the monoclonal antibody Ki-67. J. Immunol. Meth. 90, 65-70 (1986).
9. Westermann, J. & Pabst, R. Lymphocyte subsets in the blood: a diagnostic window on the lymphoid system. Immunol. Today 11, 406-410 (1990).
10. Cantrell D.A. & Smith, K.A. The interleukine-2 T-cell system: a new cell growth model. Science 224, 1312-1316 (1984).
11. Gulick, R.M. et al. Treatment with indinavir, zidovudine, and lamivudme in adults with human immunodeficiency virus infection and prior antiretroviral therapy. N. Engl. J. Med. 337, 734-739 (1997).
12. Hammer, S.M. et al. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. N. Engl. J. Med. 11, 725-733 (1997).
13. Perelson, A.S. et al. Decay characteristics of HIV-1 infected compartments during combination therapy. Nature 387, 188-191 (1997).
14. Perelson, A.S., Neumann, A.U., Markowitz, M. Leonary, J.M. & Ho, D.D. HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time. Science 271, 1582-1586 (1996).
15. + T lymphocytes as measured by Ki-67 antigen. J. Exp. Med. 187, 1295-1303 (1998).
16. + T cell repopulation of lymphoid tissues after treatment of HIV-1 infection. Proc. Natl. Acad. Sci. USA 95 1154-1159 (1998).
17. Paganin, C., Mones, D.S., Marshall, J.D., Frank, I. & Trinchieri, G. Frequency and cytokine profile of HPRT mutant T cells in HIV-infected and healthy donors: implication for T cell proliferation in HIV disease. J. Clin. Invest. 99, 663-668 (1997).
18. Hellerstein, M.K. & McCurie, J.M. T cell turnover in HIV-1 disease. Immunity 7, 583-589 (1997).
19. Clark, D.R. et al. Peripheral blood from human immunodeficiency virus type 1-infected patients display diminished T cell generation capacity. J. Infect. Dis. 176, 649-654 (1997).
20. + T lymphocytes in patients with AIDS. J. Immunol. 144, 1696-1704 (1990).
21. Margolick, J.B., Volkman, D.J., Lane, H.C. & Fauci, A.S. Clonal analysis of T lymphocytes in the acquired immunodeficiency syndrome: evidence for an abnormality affecting individual helper and suppressor T cells. J. Clin. Invest. 76, 709-711 (1985).
22. Schellekens, P.T. et al. Biphasic rate of CD4+ cell count decline during progression to AIDS correlates with HIV-1 phenotype. AIDS 6, 665 (1992).
23. Schuitemaker, H. et al. Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus population. J. Virol. 66, 1354-1361 (1992).
24. Pantaleo, G. et al. Lymphoid organs function as major reservoirs for human immunodeficiency virus. Proc. Natl. Acad. Sci. USA 88, 9838-9842 (1991).
25. Dewar, R. et al. Application of branched DNA signal amplification to monitor human immunodeficiency virus type 1 burden in plasma. J. Infect. Dis. 170, 1172-1179 (1994).
26. Press, W.H., Plannery, B.P., Teukolsky, S.A. & Vetterking, W.T. in Cambridge U.P., (Cambridge, 1988).